Literature DB >> 8830676

IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes.

J Wehinger1, F Gouilleux, B Groner, J Finke, R Mertelsmann, R M Weber-Nordt.   

Abstract

Interaction of IL-10 with its receptor leads to the activation of STAT transcription factors. Herein we report the IL-10 dependent simultaneous activation of three STAT transcription factors: Stat1, Stat3, and Stat5. Upon IL-10 treatment multiple Stat proteins become simultaneously activated, and bind to different promoters with equal kinetics but form distinct homo- and heterodimeric transcriptionally active complexes depending on the STAT-consensus elements of a selected gene promoter. Upon IL-10 treatment Stat1, 3, and 5 bind to the GRR of the FcgammaRI gene, activated Stat1 and 3 bind to the SIE sequence of the c-fos promoter and transcriptionally active Stat5 assembles at the PRL-STAT consensus sequence of the beta-casein gene. Thus, functionally relevant STAT dimerization is influenced by the activated cytokine receptor as well as the specific STAT consensus sequence present in a specific gene promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8830676     DOI: 10.1016/0014-5793(96)00990-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

1.  Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1.

Authors:  C L Bone-Larson; C M Hogaboam; M L Steinhauser; S H Oliveira; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription.

Authors:  Anne Rascle; Emma Lees
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

Review 3.  Cytokines that target immune killer cells against tumors.

Authors:  Jian Qiao; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2020-06-10       Impact factor: 11.530

4.  Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.

Authors:  Kristine Dziurzynski; Jun Wei; Wei Qiao; Mustafa Aziz Hatiboglu; Ling-Yuan Kong; Adam Wu; Yongtao Wang; Daniel Cahill; Nicholas Levine; Sujit Prabhu; Ganesh Rao; Raymond Sawaya; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2011-04-13       Impact factor: 12.531

5.  IL-10 induces a STAT3-dependent autoregulatory loop in TH2 cells that promotes Blimp-1 restriction of cell expansion via antagonism of STAT5 target genes.

Authors:  Amanda C Poholek; Dragana Jankovic; Alejandro V Villarino; Franziska Petermann; Angela Hettinga; Dror S Shouval; Scott B Snapper; Susan M Kaech; Stephen R Brooks; Golnaz Vahedi; Alan Sher; Yuka Kanno; John J O'Shea
Journal:  Sci Immunol       Date:  2016-11-11

6.  Differential T Cell Cytokine Receptivity and Not Signal Quality Distinguishes IL-6 and IL-10 Signaling during Th17 Differentiation.

Authors:  Lindsay L Jones; Rajshekhar Alli; Bofeng Li; Terrence L Geiger
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

7.  An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Authors:  M Finsterbusch; V Khare; C Campregher; R Evstatiev; C Gasche
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

8.  IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.

Authors:  A M O'Farrell; Y Liu; K W Moore; A L Mui
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

9.  Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.

Authors:  Jinpu Yu; Yue Wang; Fang Yan; Peng Zhang; Hui Li; Hua Zhao; Cihui Yan; Fan Yan; Xiubao Ren
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

10.  Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses.

Authors:  Claire Gorby; Junel Sotolongo Bellón; Stephan Wilmes; Walid Warda; Elizabeth Pohler; Paul K Fyfe; Adeline Cozzani; Christophe Ferrand; Mark R Walter; Suman Mitra; Jacob Piehler; Ignacio Moraga
Journal:  Sci Signal       Date:  2020-09-15       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.